Should the Window for Intravenous Administration of Tissue Plasminogen Activator in the Treatment of Acute Ischemic Stroke Be Extended to 4.5 Hours?

Canadian Journal of Hospital Pharmacy - Canada
doi 10.4212/cjhp.v62i3.798
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Canadian Society of Hospital Pharmacists (CSHP)


Related search